Skip to main content
Log in

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We conducted a 12-month trial of cisapride (10 mg three times a day) in 21 patients with gastric stasis due to clinically and manometrically diagnosed gastroparesis (N=9; seven due to diabetes) or chronic intestinal pseudo-obstruction (N=12). Radionuclide solid-liquid gastric emptying tests were performed at baseline and at the end of the 12-month period. Symptoms were assessed monthly by diary and every three months by the investigators; frequency and severity of symptoms were scored in a standardized manner. For the whole group of 21 patients, gastric emptying of both solids and liquids improved significantly after one year of cisapride (P<0.05). Among chronic intestinal pseudoobstruction patients, there was predominantly an improvement in gastric emptying of solids; in contrast, patients with gastroparesis had a greater improvement in liquid emptying. Total symptom score improved significantly in the gastroparesis group (median score: 8 at baseline vs 6 at one year,P<0.05) but not in the chronic intestinal pseudoobstruction patients (median score at baseline 10 vs 9 at one year). Similarly, body weight showed a trend towards improvement in the gastroparesis group. No significant side effects were noted. We conclude that during a 12-month open trial, cisapride was effective in improving gastric emptying in patients with gastric stasis and consistently improved symptoms in those with gastroparesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McCallum RW, Prakath C, Campoli-Richardo DM, Goa KL: Cisapride: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 36(6):652–681, 1988

    Google Scholar 

  2. Gilbert RJ, Dodds WJ, Kahrelias PJ, Hogen WJ, Lipman S: Effect of cisapride, a new prokinetic agent, on esophageal motor function. Dig Dis Sci 32(12):1331–6, 1987

    Google Scholar 

  3. Geldof H, van der Schee EJ, Grashius JL: Acute effects of cisapride and metoclopramide on gastric myoelectrical and motor activity in man. Gastroenterology 90:1425, 1986 (abstract)

    Google Scholar 

  4. Krevsky B, Malmud LS, Maurer A, Somers ML, Siegel JA, Fisher RS: The effect of oral cisapride on colonic transit. Aliment Pharmacol Ther 1:293–304, 1987

    Google Scholar 

  5. Camilleri M, Brown ML, Malagelada JR: Impaired transit of chyme in chronic intestinal pseudoobstruction. Gastroenterology 91(3):619–626, 1986

    Google Scholar 

  6. Camilleri M, Malagelada J-R, Abell TL, Brown MC, Hench V, Zinsmeister AR: Effect of six weeks' treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 96(3):704–712, 1989

    Google Scholar 

  7. Malagelada JR, Camilleri M, Stanghellini V: Manometric Diagnosis of Gastrointestinal Motor Disorders. New York, Thieme, 1986

    Google Scholar 

  8. Stanghellini V, Camilleri M, Malagelada JR: Chronic idiopathic intestinal pseudoobstruction: Observations on clinical and manometric findings. Gut 28(1):5–12, 1987

    Google Scholar 

  9. Thomforde GM, Brown ML, Malagelada JR: Practical solid and liquid phase markers for studying gastric emptying in man. J Nucl Med Tech 13(1):11–14, 1985

    Google Scholar 

  10. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR: Relationship between antral motility and gastricemptying of solids and liquids in humans. Am J Physiol 249(5 pt 1):G580-G585, 1985

    Google Scholar 

  11. Elashoff JD, Reeder TJ, Meyer JH: Analysis of gastric emptying data. Gastroenterology 83(6):1306–1312, 1982

    Google Scholar 

  12. Corinaldesi R, Stanghellini V, Raiti C, Rea E, Salgemini R, Barbara L: Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 28(3):300–5, 1987

    Google Scholar 

  13. Urbain JLC, Siegel JA, Debien C, Pauwele SP: Effect of cisapride on gastric emptying in dyspeptic patients. Dig Dis Sci 33(7):779–783, 1988

    Google Scholar 

  14. Feldman M, Smith HJ: Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum. Gastroenterology 92(1):171–174, 1987

    Google Scholar 

  15. Schade RR, Dugas MC, Lhotsky DM, Gavaler JS, Van Thiel DH: Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 30(1):10–15, 1985

    Google Scholar 

  16. Horowitz M, Harding PE, Chatterton BE, Collins PJ, Shearman DJ: Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 30(1):1–9, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abell, T.L., Camilleri, M., DiMagno, E.P. et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Digest Dis Sci 36, 616–620 (1991). https://doi.org/10.1007/BF01297028

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01297028

Key Words

Navigation